NYSE:MMM - 3M Stock Price, News, & Analysis

3M trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMM."

3M announced a quarterly dividend on Tuesday, August 14th. Investors of record on Friday, August 24th will be paid a dividend of $1.36 per share on Wednesday, September 12th. This represents a $5.44 annualized dividend and a yield of 2.66%. The ex-dividend date is Thursday, August 23rd. View 3M's Dividend History.

3M Co (NYSE:MMM) released its earnings results on Tuesday, July, 24th. The conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $2.58 by $0.01. The conglomerate earned $8.39 billion during the quarter, compared to analysts' expectations of $8.36 billion. 3M had a net margin of 13.44% and a return on equity of 51.31%. The firm's quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.58 earnings per share. View 3M's Earnings History.

3M is scheduled to release their next quarterly earnings announcement on Tuesday, October, 23rd 2018. View Earnings Estimates for 3M.

3M updated its FY18 earnings guidance on Tuesday, July, 24th. The company provided earnings per share (EPS) guidance of $10.20-10.45 for the period, compared to the Thomson Reuters consensus estimate of $10.33.

15 brokers have issued 1 year target prices for 3M's shares. Their predictions range from $200.00 to $285.00. On average, they expect 3M's stock price to reach $228.80 in the next year. This suggests a possible upside of 11.7% from the stock's current price. View Analyst Price Targets for 3M.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 3M in the last year. There are currently 4 sell ratings, 5 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for 3M.

Some companies that are related to 3M include Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), Baxter International (BAX), ABIOMED (ABMD), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hill-Rom (HRC), ICU Medical (ICUI), Integra Lifesciences (IART), Haemonetics (HAE), Globus Medical (GMED) and Insulet (PODD).

Headlines about MMM stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. 3M earned a news and rumor sentiment score of 0.10 on Accern's scale. They also assigned news stories about the conglomerate an impact score of 46.46 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days. View Recent Headlines for 3M.

3M's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (1.94%), Bank of New York Mellon Corp (1.15%), FMR LLC (0.98%), US Bancorp DE (0.81%), Schwab Charles Investment Management Inc. (0.65%) and Morgan Stanley (0.62%). Company insiders that own 3M stock include Eric D Hammes, Frank R Jr Little, Hak Cheol Shin, Inge G Thulin, Ippocratis Vrohidis, Ivan K Fong, James L Bauman, Jon T Lindekugel, Julie L Bushman, Khandpur K Ashish, Kimberly F Price, Marlene Mary Mcgrath, Michael F Roman, Nicholas C Gangestad and Paul A Keel. View Institutional Ownership Trends for 3M.

MMM stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Robeco Institutional Asset Management B.V., Renaissance Technologies LLC, Russell Investments Group Ltd., Los Angeles Capital Management & Equity Research Inc., Canada Pension Plan Investment Board, Acadian Asset Management LLC and PNC Financial Services Group Inc.. Company insiders that have sold 3M company stock in the last year include Frank R Jr Little, Hak Cheol Shin, Inge G Thulin, Ippocratis Vrohidis, Ivan K Fong, James L Bauman, Jon T Lindekugel, Khandpur K Ashish, Michael F Roman and Nicholas C Gangestad. View Insider Buying and Selling for 3M.

MMM stock was acquired by a variety of institutional investors in the last quarter, including Parnassus Investments CA, Charles Schwab Investment Advisory Inc., Cornerstone Wealth Management LLC, Bank of New York Mellon Corp, Morgan Stanley, Alecta Pensionsforsakring Omsesidigt, Banque Pictet & Cie SA and Massachusetts Financial Services Co. MA. View Insider Buying and Selling for 3M.

Shares of MMM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MMM stock can currently be purchased for approximately $204.77.

3M has a market capitalization of $118.47 billion and generates $31.66 billion in revenue each year. The conglomerate earns $4.86 billion in net income (profit) each year or $9.17 on an earnings per share basis. 3M employs 91,536 workers across the globe.

3M's mailing address is 3M CENTER BLDG. 220-11W-02, ST PAUL MN, 55144. The conglomerate can be reached via phone at 651-733-1110.